Responses
Regular and Young Investigator Award Abstracts
Combination Immunotherapies
860 In vivo effectiveness of tumor treating fields (TTFields) concomitant with immune checkpoint inhibitors in non-small cell lung cancer (NSCLC)
Compose a Response to This Article
Other responses
No responses have been published for this article.